Starpharma Holdings Ltd has released a press release.
Targeted DEP shows sustained superior performance
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- VivaGel phase 3 study results
- VivaGel Demonstrates Efficacy in Bacterial Vaginosis
- VivaGel condom patent grant extends coverage
- VivaGel Coated Condom Licence Agreement with Okamoto Japan
- VivaGel BV Phase 3 trials - recruitment complete
Later from Starpharma
- Starpharma licences VivaGel BV to Aspen for ANZ
- Adama Licenses Starpharmas Priostar for Novel 2,4-D
- DEP docetaxel - longer duration and increased exposure
- SPL: VivaGel condom approved for sale with launch imminent
- SPP Record Date Clarification
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma